MS Active Source

positive living with MS

set site to small textset site to medium textset site to large text Home

Copaxone (Glatiramer Acetate) ( refT3 )

The active ingredient of Copaxone , glatiramer acetate, is a synthetic compound of four amino acids. Copaxone may be given to reduce relapses in people with relapsing-remitting MS. Such people should be ambulatory (able to walk) and have had at least two relapses in the last 2 years.

Copaxone is a suitable treatment for people with RRMS who have had at least two attacks of neurological dysfunction over the proceeding two-year period.

Copaxone is given as a daily subcutaneous injection (under the skin). The dose is 20 mg (milligrams). Decisions about the length of treatment should be made by the treating physician on an individual basis.

Licensed in 2002, Copaxone is manufactured by Teva Pharmaceuticals Ltd.

Use of this product will be determind by your neurologist according to guidance layed out in the risk-sharing scheme. More information can be found by going to   www.mstrust.org.uk

More detailed prescribing information on Copaxone can be found by going to www.medicines.org.uk. Typing Copaxone into the search box and pressing Go will bring you to the patient information leaflet usually packaged with the drug.

Did you know?

How MS affects you will be very different to how it affects someone else.

Supported by

Biogen Idec

This website is intended for use in Great Britain and Northern Ireland.

Please click here for msactivesource.ie

Page last updated: 29 Jun 2009

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information: verify here.